Literature DB >> 703845

9,11-epoxyiminoprosta-5,13-dienoic acid is a thromboxane A2 antagonist in human platelets.

F A Fitzpatrick, G L Bundy, R R Gorman, T Honohan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 703845     DOI： 10.1038/275764a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

Review 1.  Current concepts for a drug-induced inhibition of formation and action of thromboxane A2.

Authors:  H Patscheke
Journal:  Blut       Date:  1990-05

2.  Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.

Authors:  K C Nicolaou; R L Magolda; J B Smith; D Aharony; E F Smith; A M Lefer
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

Review 3.  The prostanoids in hemostasis and thrombosis: a review.

Authors:  J B Smith
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

4.  Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.

Authors:  D J Fitzgerald; J Doran; E Jackson; G A FitzGerald
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

5.  Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.

Authors:  R A Coleman; P P Humphrey; I Kennedy; G P Levy; P Lumley
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

Review 6.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

7.  13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.

Authors:  G C Le Breton; D L Venton; S E Enke; P V Halushka
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

8.  Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system.

Authors:  K V Honn
Journal:  Clin Exp Metastasis       Date:  1983 Apr-Jun       Impact factor: 5.150

9.  Thromboxane synthetase inhibitors differentially antagonize thromboxane receptors in vascular smooth muscle.

Authors:  E F Smith; A M Lefer; J B Smith; K C Nicolaou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

10.  Pharmacological effects of (+/-)-11-deoxy, 16-phenoxy-prostaglandin E1 derivatives in the cardiovascular system.

Authors:  A K Banerjee; D P Tuffin; J L Walker
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.